欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/5237/001
药品名称HALDOL-Janssen Decanoat Depot, 50 mg/ml Injektionslösung
活性成分
    • haloperidol decanoate 50.0 mg
剂型Solution for injection
上市许可持有人Essential Pharma Limited Vision Exchange Building, Triq it-Territorjals, Zone 1, Central Business District CBD 1070 Birkirkara Malta
参考成员国 - 产品名称Germany (DE)
HALDOL-Janssen Decanoat Depot, 50 mg/ml Injektionslösung
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • France (FR)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Finland (FI)
    • Cyprus (CY)
    • Austria (AT)
    • Greece (GR)
许可日期2017/05/12
最近更新日期2024/03/01
药物ATC编码
    • N05AD01 haloperidol
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase